The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: A prospective randomized study

Fertility and Sterility

Volumn 95, Issue 1, 2011, Pages 216-220

  Stadtmauer, Laurel A ^a   Sarhan, Abbaa ^a   Duran, E Hakan ^a   Beydoun, Hind ^a   Bocca, Silvina ^a   Pultz, Beth ^a   Oehninger, Sergio ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

GnRH antagonist; IUI; Ovulation induction; PCOS

Indexed keywords

ESTROGEN; GANIRELIX; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ANOVULATION; ARTICLE; BIRTH RATE; DRUG EFFECT; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; INTRAUTERINE INSEMINATION; LIVE BIRTH; LUTEINIZATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY FOLLICLE; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PLEURA EFFUSION; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; DRUG THERAPY, COMBINATION; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HORMONE ANTAGONISTS; HUMANS; INFERTILITY, FEMALE; LUTEINIZING HORMONE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 78650417914     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.05.023     Document Type: Article

References (28)

1. S. Franks Polycystic ovary syndrome N Engl J Med 333 1995 853 861
2. G.S. Conway, J.W. Honour, and H.S. Jacobs Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients Clin Endocrinol 30 1989 459 470
3. E. Hughes, J. Collins, and P. Vandekerckhove Clomiphene citrate for ovulation induction in women with oligo-amenorrhoea Cochrane Database Syst Rev 2000 (2):CD000056
4. L. Stadtmauer, and S. Oehninger Management of infertility in women with polycystic ovary syndrome: a practical guide Treat Endocrinol 4 2005 279 292
5. D. Nugent, P. Vandekerckhove, E. Hughes, M. Arnot, and R. Lilford Gonadotropin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome Cochrane Database Syst Rev 2000 (4):CD000410
6. E. Loumaye, L. Vankrieken, S. Depreester, I. Psalti, S. de Cooman, and K. Thomas Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development Fertil Steril 51 1989 105 111
7. R. Homburg, N.A. Armar, A. Eshel, J. Adams, and H.S. Jacobs Influence of serum luteinizing hormone concentration on ovulation, conception and early pregnancy loss in polycystic ovary syndrome Br Med J 297 1988 1024 1026
8. A.H. Balen, S.L. Tan, and H.S. Jacobs Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage Br J Obstet Gynaecol 100 1993 1082 1089
9. B.C. Tarlatzis, G. Grimbizis, F. Pournaropoulos, J. Bontis, S. Lagos, and E. Spanos The prognostic value of basal luteinizing hormone: follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques Hum Reprod 10 1995 2545 2549
10. D. Kenisberg, B.A. Littman, and G.D. Hodgen Medical hypophysectomy. I. Dose-response using a gonadotropin-releasing hormone antagonist Fertil Steril 42 1984 112 115
11. I. Leroy, M. d'Acremont, S. Brailly-Tabard, R. Frydman, J. de Mouzon, and P. Bouchard A single injection of a LH-RH-a (cetrorelix) postpones the LH surge: further evidence for the role of LH-RH during the LH surge Fertil Steril 62 1994 461 467
12. J.J. Oberye, B.M. Mannaerts, J.A. Huisman, and C.J. Timmer Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers Fertil Steril 72 1999 1006 1012
13. C. Albano, R.E. Felberbaum, J. Smitz, H. Riethmüller-Winzen, J. Engel, and K. Diedrich Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group Hum Reprod 15 2000 526 531
14. F. Olivennes, J. Belaisch-Allart, J.C. Emperaire, H. Dechaud, S. Alvarez, and L. Moreau Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin) Fertil Steril 73 2000 314 320
15. M. Fluker, J. Grifo, A. Leader, M. Levy, D. Meldrum, and S.J. Muasher Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation Fertil Steril 75 2001 38 45
16. Ganirelix Dose-Finding Study Group A double-blind, randomized, hormone antagonist Ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) Hum Reprod 13 1998 3023 3031
17. M.A. Aboulghar, R.T. Mansour, G.I. Serour, H.G. Al-Inany, Y.M. Amin, and M.M. Aboulghar Increasing dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial Reprod BioMed Online 8 2004 524 527
18. H.G. Al-Inany, A.M. Abou-Setta, and M. Aboulghar Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review Reprod Biomed Online 14 2007 640 649
19. E.M. Kolibianakis, K. Zikopoulos, J. Smitz, M. Camus, H. Tournaye, and A.C. Van Steirteghem Elevated progesterone at initiation of stimulation is associated with lower ongoing pregnancy rate after IVF using GnRH antagonists Hum Reprod 19 2004 1525 1529
20. E.M. Kolibianakis, C. Albano, J. Kahn, M. Camus, H. Tournaye, and A.C. Van Steirteghem Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy Fertil Steril 79 2003 873 880
21. E.M. Kolibianakis, K. Zikopoulos, J. Smitz, M. Camus, H. Tournaye, and A.C. Van Steirteghem Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in-vitro fertilization Fertil Steril 82 2004 223 226
22. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
23. K.E. Elkind-Hirsch, B.W. Webster, C.P. Brown, and M.W. Vernon Concurrent ganirelix and follitropin-beta therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome Fertil Steril 79 2003 603 607
24. V.S. Cardone GnRH antagonist for treatment of polycystic ovarian syndrome Fertil Steril 80 2003 S25 S29
25. D. Ertunc, E.C. Tok, A. Savas, I. Ozturk, and S. Dilek Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome Fertil Steril 93 2010 1179 1184
26. A. Tavaniotou, and P. Devroey Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles Reprod Biomed Online 13 2006 326 330
27. R.S. Williams, J.B. Hillard, G. De Vane, T. Yeko, S. Kipersztok, and A. Rhoton-Vlasak A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation IUI therapy Am J Obstet Gynecol 191 2004 648 651
28. J.L. Gómez-Palomares, B. Juliá, B. Acevedo-Martín, M. Martínez-Burgos, E.R. Hernández, and E. Ricciarelli Timing ovulation for intrauterine insemination with a GnRH antagonist Hum Reprod 20 2005 368 372